By Ilan Zipkin
Staff Writer

While real life experiments are usually time-consuming and expensive, computer simulation holds the potential to save drug companies time and money by focusing research efforts. By building predictive, integrative models based on available scientific knowledge about a particular disease, Entelos Inc. hopes its PhysioLabs disease simulation systems will help guide experiments and increase the chances of producing approvable drugs.